Clinical Trial Update: A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

View source ↗

Summary

This is an ongoing clinical trial update evaluating the effectiveness, safety, and long-term outcomes of odevixibat (Bylvay) in participants with Progressive Fa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• Odevixibat (Bylvay) (odevixibat)

Snippet

Sponsor: Ipsen | Conditions: Progressive Familial Intrahepatic Cholestasis | Status: RECRUITING